Abstract:Abstract Structured RNA regulatory motifs exist from the prebiotic stages of the RNA world to the more complex eukaryotic systems. In cases where a functional RNA structure is within the coding sequence a selective pressure drives a parallel co-evolution of the RNA structure and the encoded peptide domain. The p53-MDM2 axis, describing the interactions between the p53 tumor suppressor and the MDM2 E3 ubiquitin ligase, serves as particularly useful model revealing how secondary RNA structures have co-evolved along with corresponding interacting protein motifs, thus having an impact on protein – RNA and protein – protein interactions; and how such structures developed signal-dependent regulation in mammalian systems. The p53(BOX-I) RNA sequence binds the C-terminus of MDM2 and controls p53 synthesis while the encoded peptide domain binds MDM2 and controls p53 degradation. The BOX-I peptide domain is also located within p53 transcription activation domain. The folding of the p53 mRNA structure has evolved from temperature-regulated in pre-vertebrates to an ATM kinase signal-dependent pathway in mammalian cells. The protein – protein interaction evolved in vertebrates and became regulated by the same signaling pathway. At the same time the protein - RNA and protein - protein interactions evolved, the p53 trans-activation domain progressed to become integrated into a range of cellular pathways. We discuss how a single synonymous mutation in the BOX-1, the p53(L22 L), observed in a chronic lymphocyte leukaemia patient, prevents the activation of p53 following DNA damage. The concepts analysed and discussed in this review may serve as a conceptual mechanistic paradigm of the co-evolution and function of molecules having roles in cellular regulation, or the aetiology of genetic diseases and how synonymous mutations can affect the encoded protein.

The p53 mRNA-Mdm2 interaction

p53 mRNA controls p53 activity by managing Mdm2 functions

Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26

Inhibition of Nonsense-Mediated Decay Rescues P53β/γ Isoform Expression and Activates the P53 Pathway in MDM2-overexpressing and Select P53-Mutant Cancers

Inhibition of Nonsense-Mediated Decay Rescues Functional P53β/γ Isoforms in MDM2-amplified Cancers

Negative Regulation of p53 Functions by Daxx and the Involvement of MDM2

The Regulation of the P53/mdm2 Feedback Loop by Micrornas.

P300/mdm2 Complexes Participate in MDM2-mediated P53 Degradation.

Positive and negative feedback loops in the p53 and mRNA 3′ processing pathways

The P53 Isoforms Are Differentially Modified by Mdm2

Mdm2 is A Negative Regulator of P21(Waf1/Cip1), Independent of P53

Interplay Between MDM2, MDMX, Pirh2 and COP1: the Negative Regulators of P53

Small Molecule Inhibitors of the P53-Mdm2

Shaping the regulation of the p53 mRNA tumour suppressor: the co-evolution of genetic signatures

Modulation of the p53-MDM2 Interaction by Phosphorylation of Thr18: A Computational Study

Ribosomal Protein S7 As a Novel Modulator of P53–mdm2 Interaction: Binding to MDM2, Stabilization of P53 Protein, and Activation of P53 Function

The Regulation of MDM2 Oncogene and Its Impact on Human Cancers

Ribosomal Protein S27-like and S27 Interplay with P53-Mdm2 Axis As a Target, a Substrate and a Regulator.

Complex Structures of Human MDM2 with Interacting Proteins Reveal the Regulation Mechanism of P53

Characterization of cancer-associated missense mutations in MDM2

Scission of the P53-Mdm2 Loop by Ribosomal Proteins.